Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$240.4K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 9 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 9 most recent Form 4 transactions.
| Mar 17 | PCRX | Pacira BioSciences, Inc. | SSELL◷ | 3,261 | $22.82 | $74.4K | -1.4% | Open the original filing on SEC.gov |
| Feb 11 | PCRX | Pacira BioSciences, Inc. | AGRANT | 54,546 | — | — | +31.6% | Open the original filing on SEC.gov |
| Jan 30 | PCRX | Pacira BioSciences, Inc. | FTAX | 6,168 | $20.54 | $126.7K | -3.5% | Open the original filing on SEC.gov |
| Jan 2 | PCRX | Pacira BioSciences, Inc. | FTAX | 381 | $24.46 | $9.3K | -0.2% | Open the original filing on SEC.gov |
| Nov 17, 2025 | PCRX | Pacira BioSciences, Inc. | SSELL◷ | 3,960 | $24.09 | $95.4K | -2.2% | Open the original filing on SEC.gov |
| Aug 1, 2025 | PCRX | Pacira BioSciences, Inc. | FTAX | 315 | $22.07 | $7K | -0.2% | Open the original filing on SEC.gov |
| Jun 3, 2025 | PCRX | Pacira BioSciences, Inc. | FTAX | 5,084 | $26.40 | $134.2K | -2.7% | Open the original filing on SEC.gov |